{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T08:43:30Z","timestamp":1772268210370,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Conselho Nacional de Desenvolvimento Cientifico (CNPq)"},{"DOI":"10.13039\/501100004263","name":"FAPERGS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fundo de Incentivo a Pesquisa do HCPA (FIPE-HCPA)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.ymgme.2013.03.005","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T08:36:20Z","timestamp":1363422980000},"page":"33-40","source":"Crossref","is-referenced-by-count":56,"title":["Enzyme replacement therapy started at birth improves outcome in difficult-to-treat organs in mucopolysaccharidosis I mice"],"prefix":"10.1016","volume":"109","author":[{"given":"Guilherme","family":"Baldo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana Q.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara Z.","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talita G.","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiola S.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia G.","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luise","family":"Meurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c2ngela","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Matte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2013.03.005_bb0160","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.ymgme.2013.03.005_bb0165","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S1415-47572010005000093","article-title":"Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment","volume":"33","author":"Giugliani","year":"2010","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0015","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10545-011-9350-4","article-title":"Cell microencapsulation: a potential tool for the treatment of neuronopathic lysosomal storage diseases","volume":"34","author":"Matte","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0170","doi-asserted-by":"crossref","first-page":"60ra89","DOI":"10.1126\/scitranslmed.3001380","article-title":"Replacing the enzyme alpha-l-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I","volume":"2","author":"Dierenfeld","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0175","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1542\/peds.2006-2156","article-title":"Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-l-iduronidase (laronidase)","volume":"120","author":"Wraith","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2013.03.005_bb0030","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1542\/peds.2009-1728","article-title":"Enzyme replacement therapy in a 5-month-old boy with attenuated presymptomatic MPS I: 5-year follow-up","volume":"125","author":"Gabrielli","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2013.03.005_bb0035","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1203\/00006450-199906000-00010","article-title":"Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy","volume":"45","author":"Vogler","year":"1999","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ymgme.2011.03.002","article-title":"Placenta analysis of prenatally diagnosed patients reveals early GAG storage in mucopolysaccharidoses II and VI","volume":"103","author":"Baldo","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbr.2012.04.051","article-title":"Evidence of a progressive motor dysfunction in Mucopolysaccharidosis type I mice","volume":"233","author":"Baldo","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ymgme.2008.10.009","article-title":"A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I","volume":"96","author":"Giugliani","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0055","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000327532","article-title":"Recombinant encapsulated cells overexpressing alpha-l-iduronidase correct enzyme deficiency in human mucopolysaccharidosis type I cells","volume":"195","author":"Baldo","year":"2012","journal-title":"Cells Tissues Organs."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0060","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0180","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ymgme.2011.08.018","article-title":"Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation","volume":"104","author":"Baldo","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0070","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.lfs.2010.10.008","article-title":"Bone marrow derived cells decrease inflammation but not oxidative stress in an experimental model of acute myocardial infarction","volume":"87","author":"Tavares","year":"2010","journal-title":"Life Sci."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0075","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1152\/ajpheart.00979.2001","article-title":"Serial noninvasive assessment of progressive pulmonary hypertension in a rat model","volume":"283","author":"Jones","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0080","unstructured":"G. Baldo, D. Wozniak, K. Ohlemiller, Y. Zhang, R. Giugliani R, K.P. Ponder, Retroviral Vector-mediated Gene Therapy to Mucopolysaccharidosis I Mice Improves Sensorimotor Impairments and Other Behavior Deficits, J Inherit Metab Dis. in press."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0085","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.brainres.2007.10.036","article-title":"Progression of multiple behavioral deficits with various ages of onset in a murine model of Hurler syndrome","volume":"1188","author":"Pan","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0090","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3109\/14653249.2012.672730","article-title":"Intraperitoneal implant of recombinant encapsulated cells overexpressing alpha-l-iduronidase partially corrects visceral pathology in Mucopolysaccharidosis type I mice","volume":"14","author":"Baldo","year":"2012","journal-title":"Cytotherapy"},{"key":"10.1016\/j.ymgme.2013.03.005_bb0095","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, doubleblinded, placebo-controlled, multinational study of recombinant human alpha-l-iduronidase (laronidase)","volume":"144","author":"Wraith","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0105","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1172\/JCI1773","article-title":"Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function","volume":"101","author":"O'Connor","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0110","doi-asserted-by":"crossref","first-page":"35765","DOI":"10.1074\/jbc.M705124200","article-title":"Lysosomal dysfunction results in altered energy balance","volume":"282","author":"Woloszynek","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0185","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.amjcard.2006.02.047","article-title":"Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I","volume":"98","author":"Braunlin","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2006.08.007","article-title":"A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6years","volume":"90","author":"Sifuentes","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1017\/S1047951110002015","article-title":"Aortic stenosis in a patient with Hurler's syndrome after bone marrow transplantation","volume":"21","author":"Watanabe","year":"2011","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.ymgme.2013.03.005_bb0130","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymgme.2008.03.018","article-title":"Upregulation of elastase proteins results in aortic dilatation in mucopolysaccharidosis I mice","volume":"94","author":"Ma","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/mgme.2000.3140","article-title":"Enzyme replacement therapy in feline mucopolysaccharidosis I","volume":"72","author":"Kakkis","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0140","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ymgme.2009.07.015","article-title":"Treatment reduces or stabilizes brain imaging abnormalities in patients with MPS I and II","volume":"98","author":"Wang","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10545-010-9059-9","article-title":"Efficacy of recombinant human alpha-l-iduronidase (laronidase) on restricted range of motion of upper extremities in mucopolysaccharidosis type I patients","volume":"33","author":"Tylki-Szymanska","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2013.03.005_bb0150","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(03)13311-9","article-title":"Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I","volume":"361","author":"Kakavanos","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2013.03.005_bb0155","first-page":"2686","article-title":"Immune response hinders therapy for lysosomal storage diseases","volume":"118","author":"Ponder","year":"2008","journal-title":"J. Clin. Invest."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213000942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719213000942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T17:01:03Z","timestamp":1644598863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719213000942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1096719213000942"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2013.03.005","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}